<!DOCTYPE html>
<html lang="fr" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Les Antidiab√©tiques - IFSI</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://unpkg.com/lucide@latest"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&display=swap" rel="stylesheet">
    <style>
        html {
            overflow-y: scroll; /* Force the scrollbar to always be visible, preventing layout shifts */
        }
        body {
            font-family: 'Inter', sans-serif;
            background-color: #f0f4f8;
        }
        /* Animation for page transitions */
        .page {
            animation: fadeIn 0.5s ease-in-out;
        }
        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }
        /* Quiz specific styles */
        .qcm-option.correct {
            background-image: linear-gradient(to right, #4ade80, #16a34a); /* from-green-400 to-green-600 */
            color: white;
            border-color: #15803d; /* green-700 */
            font-weight: 600;
        }
        .qcm-option.incorrect {
            background-image: linear-gradient(to right, #f87171, #dc2626); /* from-red-400 to-red-600 */
            color: white;
            border-color: #b91c1c; /* red-700 */
            font-weight: 600;
        }
        .qcm-option:disabled {
            cursor: not-allowed;
        }
        .qcm-option:disabled:not(.correct):not(.incorrect) {
            color: #475569; /* slate-600 */
            background-color: #f1f5f9; /* slate-100 */
            opacity: 0.7;
        }
    </style>
</head>
<body class="p-2 sm:p-4 md:p-8">
    <!-- Main container with rounded corners and shadow -->
    <div class="max-w-6xl mx-auto bg-white rounded-xl shadow-2xl overflow-hidden">
        <!-- Header -->
        <header class="bg-slate-800 text-white p-6 md:p-8">
            <div class="flex items-center justify-between">
                <h1 class="text-3xl sm:text-4xl md:text-5xl font-black tracking-tight bg-gradient-to-r from-violet-400 to-indigo-500 bg-clip-text text-transparent pb-2">Les Antidiab√©tiques</h1>
                <div class="hidden md:flex text-right font-bold text-slate-300 text-sm">
                    <p>Lucas S√©raudie - <span class="bg-gradient-to-r from-violet-400 to-indigo-500 bg-clip-text text-transparent">IFSI du CHU de Rouen</span> - 2025</p>
                </div>
            </div>
        </header>

        <!-- Navigation bar -->
        <nav class="bg-white sticky top-0 z-10 p-4 shadow-md">
            <div class="p-1.5 bg-slate-200/60 rounded-xl grid grid-cols-2 sm:grid-cols-4 md:grid-cols-7 gap-2">
                <button data-page="generalites" onclick="showPage('generalites')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">G√©n√©ralit√©s</button>
                <button data-page="dt1" onclick="showPage('dt1')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">Diab√®te Type I</button>
                <button data-page="insulines" onclick="showPage('insulines')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">Insulines</button>
                <button data-page="dt2" onclick="showPage('dt2')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">Diab√®te Type II</button>
                <button data-page="ado" onclick="showPage('ado')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">ADO</button>
                <button data-page="role" onclick="showPage('role')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">R√¥le Infirmier</button>
                <button data-page="quiz" onclick="showPage('quiz')" class="nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm">Quiz</button>
            </div>
        </nav>

        <!-- Main content -->
        <main class="p-4 sm:p-6 md:p-8">
            <!-- Section 1: Generalities -->
            <div id="generalites" class="page">
                <section class="bg-gradient-to-br from-violet-100 to-purple-100 rounded-2xl p-6 md:p-12">
                    <h3 class="text-3xl sm:text-4xl md:text-5xl font-extrabold mb-12 text-center leading-tight text-slate-800"><span class="bg-gradient-to-br from-violet-500 to-purple-600 bg-clip-text text-transparent">Le Diab√®te : G√©n√©ralit√©s</span></h3>
                    <div class="space-y-8">
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 transition-all duration-300 hover:shadow-2xl hover:-translate-y-1"><div class="flex items-center gap-4 mb-4"><div class="bg-blue-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="microscope" class="text-blue-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">D√©finition & Diagnostic</h4></div><p class="text-slate-600 mb-4">Pr√©sence d'une hyperglyc√©mie chronique due √† une carence (relative ou absolue) en insuline.</p><div class="grid md:grid-cols-2 gap-4 text-sm"><div class="p-4 bg-blue-50 rounded-lg"><h5 class="font-semibold text-blue-800">Glyc√©mie √† jeun</h5><p>Diab√®te si <strong>> 1,26 g/L (7 mmol/L)</strong> √† deux reprises.</p></div><div class="p-4 bg-blue-50 rounded-lg"><h5 class="font-semibold text-blue-800">N'importe quand</h5><p>Diab√®te si <strong>> 2 g/L (11,1 mmol/L)</strong> avec des sympt√¥mes.</p></div></div></div>
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 transition-all duration-300 hover:shadow-2xl hover:-translate-y-1"><div class="flex items-center gap-4 mb-4"><div class="bg-red-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="heart-pulse" class="text-red-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Complications √† long terme</h4></div><div class="grid md:grid-cols-2 gap-4 text-sm"><div class="p-4 bg-red-50 rounded-lg"><h5 class="font-semibold text-red-800">Macroangiopathies</h5><p>Atteinte des gros vaisseaux : AVC, infarctus du myocarde, art√©rite des membres inf√©rieurs.</p></div><div class="p-4 bg-orange-50 rounded-lg"><h5 class="font-semibold text-orange-800">Microangiopathies</h5><p><strong>R√©tinopathie</strong> (yeux), <strong>N√©phropathie</strong> (reins), <strong>Neuropathie</strong> (nerfs), menant au mal perforant plantaire.</p></div></div></div>
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 transition-all duration-300 hover:shadow-2xl hover:-translate-y-1"><div class="flex items-center gap-4 mb-4"><div class="bg-green-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="clipboard-check" class="text-green-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Surveillance Cl√©</h4></div><div class="flex flex-wrap gap-4 text-sm"><div class="flex-1 min-w-[200px] p-4 bg-green-50 rounded-lg"><h5 class="font-semibold text-green-800">HbA1c (H√©moglobine glyqu√©e)</h5><p>Reflet de l'√©quilibre glyc√©mique sur 3 mois. Objectif < 7% pour la plupart des patients.</p></div><div class="flex-1 min-w-[200px] p-4 bg-green-50 rounded-lg"><h5 class="font-semibold text-green-800">Annuelle</h5><p>Fond d'≈ìil, bilan r√©nal (cr√©atinine, prot√©inurie), bilan lipidique, examen des pieds, ECG.</p></div></div></div>
                    </div>
                </section>
            </div>
            
            <div id="dt1" class="page hidden">
                <section class="bg-gradient-to-br from-teal-100 to-cyan-100 rounded-2xl p-6 md:p-12">
                    <h3 class="text-3xl sm:text-4xl md:text-5xl font-extrabold mb-12 text-center leading-tight text-slate-800"><span class="bg-gradient-to-br from-teal-500 to-cyan-600 bg-clip-text text-transparent">Diab√®te de Type I (DID)</span></h3>
                    <div class="space-y-8">
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6"><div class="flex items-center gap-4 mb-4"><div class="bg-emerald-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="shield-x" class="text-emerald-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Physiopathologie & Clinique</h4></div><p class="text-slate-600 mb-4">Maladie auto-immune menant √† la destruction des cellules Œ≤ du pancr√©as, provoquant une <strong>carence absolue en insuline</strong>. Touche le sujet jeune (< 20 ans) avec une survenue brutale.</p><div class="p-4 bg-emerald-50 rounded-lg"><h5 class="font-semibold text-emerald-800">Syndrome Cardinal</h5><p class="text-sm">Polyurie (urine abondante), Polydipsie (soif intense), Polyphagie (faim excessive), Amaigrissement.</p></div></div>
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6"><div class="flex items-center gap-4 mb-4"><div class="bg-orange-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="alert-triangle" class="text-orange-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Complications Aigu√´s</h4></div><div class="grid md:grid-cols-2 gap-4 text-sm"><div class="p-4 bg-orange-50 rounded-lg"><h5 class="font-semibold text-orange-800">Acidoc√©tose Diab√©tique</h5><p>Urgence vitale. Carence en insuline ‚Üí production de corps c√©toniques ‚Üí acidose. <strong>Signes :</strong> dyspn√©e de Kussmaul, haleine c√©tonique, d√©shydratation, coma. <strong>TTT :</strong> r√©hydratation + insulinoth√©rapie IV.</p></div><div class="p-4 bg-red-50 rounded-lg"><h5 class="font-semibold text-red-800">Hypoglyc√©mie (< 0,6 g/L)</h5><p>Due au traitement. <strong>Signes neurov√©g√©tatifs :</strong> sueurs, tremblements, palpitations. <strong>Signes de souffrance c√©r√©brale :</strong> troubles de la vue, confusion, coma. <strong>TTT :</strong> resucrage per os si conscient, Glucagon IM ou G30% IV si inconscient.</p></div></div></div>
                    </div>
                </section>
            </div>

            <div id="insulines" class="page hidden">
                <section class="bg-gradient-to-br from-sky-100 to-blue-100 rounded-2xl p-6 md:p-12">
                    <h3 class="text-3xl sm:text-4xl md:text-5xl font-extrabold mb-12 text-center leading-tight text-slate-800"><span class="bg-gradient-to-br from-sky-500 to-blue-600 bg-clip-text text-transparent">Les Insulines</span></h3>
                    <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-8">
                        <!-- Rapides Card -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800 mb-2">Analogues Ultra-Rapides</h4>
                            <p class="text-xs text-slate-500 italic mb-4">Novorapid¬Æ, Humalog¬Æ, Apidra¬Æ</p>
                            <div class="space-y-3 text-sm flex-grow">
                                <p class="flex items-center gap-2"><i data-lucide="zap" class="w-4 h-4 text-yellow-500"></i><strong>D√©lai action :</strong> 15 min</p>
                                <p class="flex items-center gap-2"><i data-lucide="bar-chart-2" class="w-4 h-4 text-sky-500"></i><strong>Pic :</strong> ~1h</p>
                                <p class="flex items-center gap-2"><i data-lucide="hourglass" class="w-4 h-4 text-slate-500"></i><strong>Dur√©e :</strong> 2-5h</p>
                                <p class="flex items-center gap-2"><i data-lucide="syringe" class="w-4 h-4 text-blue-500"></i><strong>R√¥le :</strong> Contr√¥ler la glyc√©mie des repas (bolus). Injecter juste avant ou apr√®s le repas.</p>
                            </div>
                        </div>
                        <!-- Interm√©diaires Card -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800 mb-2">Insulines Interm√©diaires (NPH)</h4>
                            <p class="text-xs text-slate-500 italic mb-4">Insulatard¬Æ, Umuline NPH¬Æ</p>
                            <div class="space-y-3 text-sm flex-grow">
                                <p class="flex items-center gap-2"><i data-lucide="zap" class="w-4 h-4 text-yellow-500"></i><strong>D√©lai action :</strong> 90 min</p>
                                <p class="flex items-center gap-2"><i data-lucide="bar-chart-2" class="w-4 h-4 text-sky-500"></i><strong>Pic :</strong> 4-8h</p>
                                <p class="flex items-center gap-2"><i data-lucide="hourglass" class="w-4 h-4 text-slate-500"></i><strong>Dur√©e :</strong> 12-18h</p>
                                <p class="flex items-center gap-2"><i data-lucide="syringe" class="w-4 h-4 text-blue-500"></i><strong>R√¥le :</strong> Couverture basale. Apparence laiteuse, √† agiter avant emploi.</p>
                            </div>
                        </div>
                        <!-- Lentes Card -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800 mb-2">Analogues Lents</h4>
                            <p class="text-xs text-slate-500 italic mb-4">Lantus¬Æ, Levemir¬Æ, Toujeo¬Æ</p>
                            <div class="space-y-3 text-sm flex-grow">
                                <p class="flex items-center gap-2"><i data-lucide="zap" class="w-4 h-4 text-yellow-500"></i><strong>D√©lai action :</strong> 2-4h</p>
                                <p class="flex items-center gap-2"><i data-lucide="bar-chart-2" class="w-4 h-4 text-sky-500"></i><strong>Pic :</strong> Pas de pic marqu√©</p>
                                <p class="flex items-center gap-2"><i data-lucide="hourglass" class="w-4 h-4 text-slate-500"></i><strong>Dur√©e :</strong> ~24h</p>
                                <p class="flex items-center gap-2"><i data-lucide="syringe" class="w-4 h-4 text-blue-500"></i><strong>R√¥le :</strong> Assurer les besoins de base en insuline (basal). Ne pas m√©langer.</p>
                            </div>
                        </div>
                    </div>
                     <div class="mt-8 bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6">
                        <h4 class="text-xl sm:text-2xl font-bold text-slate-800 mb-4">Sch√©ma "Basal-Bolus"</h4>
                        <p class="text-slate-600">Le sch√©ma le plus courant pour le DT1. Il mime la s√©cr√©tion naturelle du pancr√©as :</p>
                        <ul class="list-disc list-inside space-y-2 mt-4 text-slate-700 text-sm">
                            <li><strong>1 √† 2 injections d'insuline lente ou interm√©diaire</strong> par jour pour couvrir les besoins de base (le "basal").</li>
                            <li><strong>1 injection d'insuline ultra-rapide avant chaque repas</strong> pour g√©rer l'apport en glucides (le "bolus").</li>
                        </ul>
                     </div>
                </section>
            </div>
            
            <div id="dt2" class="page hidden">
                <section class="bg-gradient-to-br from-orange-100 to-red-100 rounded-2xl p-6 md:p-12">
                    <h3 class="text-3xl sm:text-4xl md:text-5xl font-extrabold mb-12 text-center leading-tight text-slate-800"><span class="bg-gradient-to-br from-orange-500 to-red-600 bg-clip-text text-transparent">Diab√®te de Type II (DNID)</span></h3>
                    <div class="space-y-8">
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6"><div class="flex items-center gap-4 mb-4"><div class="bg-amber-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="move-3d" class="text-amber-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Physiopathologie & Clinique</h4></div><p class="text-slate-600 mb-4">Le plus fr√©quent (85%). Apparition progressive chez le sujet > 40 ans, souvent en surpoids. L'organisme d√©veloppe une <strong>insulinor√©sistance</strong> (les cellules r√©pondent mal √† l'insuline), puis le pancr√©as s'√©puise (<strong>insulinod√©ficience relative</strong>).</p><div class="p-4 bg-amber-50 rounded-lg"><h5 class="font-semibold text-amber-800">Facteurs de risque</h5><p class="text-sm">G√©n√©tique, ob√©sit√©, s√©dentarit√©.</p></div></div>
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6"><div class="flex items-center gap-4 mb-4"><div class="bg-green-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="scale-3d" class="text-green-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Strat√©gie Th√©rapeutique</h4></div><div class="flex flex-wrap gap-4 text-sm"><div class="flex-1 min-w-[200px] p-4 bg-green-50 rounded-lg"><h5 class="font-semibold text-green-800">1. R√®gles Hygi√©no-Di√©t√©tiques</h5><p>Perte de poids, alimentation √©quilibr√©e, activit√© physique. Peut suffire au d√©but.</p></div><div class="flex-1 min-w-[200px] p-4 bg-green-50 rounded-lg"><h5 class="font-semibold text-green-800">2. Monoth√©rapie (Metformine)</h5><p>Si √©chec des RHD apr√®s 3-6 mois, introduction de la metformine.</p></div><div class="flex-1 min-w-[200px] p-4 bg-green-50 rounded-lg"><h5 class="font-semibold text-green-800">3. Bi- ou Trith√©rapie / Insulinoth√©rapie</h5><p>Ajout d'autres ADO si HbA1c > 7%. Passage √† l'insuline si l'√©quilibre n'est pas atteint.</p></div></div></div>
                    </div>
                </section>
            </div>

            <div id="ado" class="page hidden">
                <section class="bg-gradient-to-br from-rose-100 to-pink-100 rounded-2xl p-6 md:p-12">
                     <h3 class="text-3xl sm:text-4xl md:text-5xl font-extrabold mb-12 text-center leading-tight text-slate-800"><span class="bg-gradient-to-br from-rose-500 to-pink-600 bg-clip-text text-transparent">Antidiab√©tiques Oraux (ADO)</span></h3>
                     <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-8">
                        <!-- Biguanides -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800">Biguanides</h4><p class="text-xs text-slate-500 italic">Metformine (Glucophage¬Æ)</p>
                            <div class="mt-4 space-y-3 text-sm flex-grow">
                                <p><strong class="text-rose-700">M√©canisme :</strong> Diminue la production de glucose par le foie et l'insulinor√©sistance. Ne provoque pas d'hypoglyc√©mie.</p>
                                <p><strong class="text-rose-700">EI majeurs :</strong> Troubles digestifs, acidose lactique (rare mais grave).</p>
                                <p><strong class="text-rose-700">CI :</strong> Insuffisance r√©nale s√©v√®re, hypoxie.</p>
                            </div>
                        </div>
                        <!-- Sulfamides -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800">Sulfamides Hypoglyc√©miants</h4><p class="text-xs text-slate-500 italic">Glibenclamide, Gliclazide (Diamicron¬Æ)</p>
                            <div class="mt-4 space-y-3 text-sm flex-grow">
                                <p><strong class="text-rose-700">M√©canisme :</strong> Stimulent la s√©cr√©tion d'insuline par le pancr√©as.</p>
                                <p><strong class="text-rose-700">EI majeurs :</strong> Hypoglyc√©mie (risque principal !), prise de poids.</p>
                                <p><strong class="text-rose-700">CI :</strong> Insuffisance r√©nale ou h√©patique s√©v√®re.</p>
                            </div>
                        </div>
                        <!-- Glinides -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800">Glinides</h4><p class="text-xs text-slate-500 italic">R√©paglinide (Novonorm¬Æ)</p>
                            <div class="mt-4 space-y-3 text-sm flex-grow">
                                <p><strong class="text-rose-700">M√©canisme :</strong> Similaire aux sulfamides, mais action plus rapide et plus courte.</p>
                                <p><strong class="text-rose-700">EI majeurs :</strong> Hypoglyc√©mie (surtout si le repas est saut√©).</p>
                                <p><strong class="text-rose-700">Usage :</strong> Prise juste avant les repas.</p>
                            </div>
                        </div>
                        <!-- Inhibiteurs DPP-4 -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800">Inhibiteurs de la DPP-4 (Gliptines)</h4><p class="text-xs text-slate-500 italic">Sitagliptine (Januvia¬Æ)</p>
                            <div class="mt-4 space-y-3 text-sm flex-grow">
                                <p><strong class="text-rose-700">M√©canisme :</strong> Augmentent la dur√©e de vie des incr√©tines (hormones stimulant la s√©cr√©tion d'insuline glucose-d√©pendante).</p>
                                <p><strong class="text-rose-700">EI majeurs :</strong> Bien tol√©r√©s, faible risque d'hypoglyc√©mie.</p>
                            </div>
                        </div>
                        <!-- Inhibiteurs SGLT2 -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800">Inhibiteurs du SGLT2 (Gliflozines)</h4><p class="text-xs text-slate-500 italic">Canagliflozine (Invokana¬Æ)</p>
                            <div class="mt-4 space-y-3 text-sm flex-grow">
                                <p><strong class="text-rose-700">M√©canisme :</strong> Bloquent la r√©absorption du glucose par le rein, provoquant une glycosurie (√©limination du sucre dans les urines).</p>
                                <p><strong class="text-rose-700">EI majeurs :</strong> Infections g√©nito-urinaires, polyurie, risque de d√©shydratation.</p>
                            </div>
                        </div>
                         <!-- Autres -->
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 flex flex-col transition-all duration-300 hover:shadow-2xl hover:-translate-y-1">
                            <h4 class="text-xl font-bold text-slate-800">Autres Classes</h4><p class="text-xs text-slate-500 italic">Analogues du GLP-1, Inhibiteurs des Œ±-glucosidases</p>
                            <div class="mt-4 space-y-3 text-sm flex-grow">
                                <p><strong class="text-rose-700">Analogues GLP-1 (injectables) :</strong> Miment les incr√©tines, favorisent la perte de poids. EI : troubles digestifs.</p>
                                <p><strong class="text-rose-700">Inhibiteurs des Œ±-glucosidases :</strong> Ralentissent l'absorption des glucides. EI : flatulences.</p>
                            </div>
                        </div>
                     </div>
                </section>
            </div>

            <div id="role" class="page hidden">
                 <section class="bg-gradient-to-br from-indigo-100 to-blue-100 rounded-2xl p-6 md:p-12">
                    <h3 class="text-3xl sm:text-4xl md:text-5xl font-extrabold mb-12 text-center leading-tight text-slate-800"><span class="bg-gradient-to-br from-indigo-500 to-blue-600 bg-clip-text text-transparent">Le R√¥le Infirmier</span></h3>
                    <div class="space-y-6">
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 transition-all duration-300 hover:shadow-2xl hover:-translate-y-1"><div class="flex items-center gap-4 mb-4"><div class="bg-indigo-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="book-user" class="text-indigo-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">√âducation Th√©rapeutique du Patient (ETP)</h4></div><p class="text-slate-600">C'est le pilier de la prise en charge. L'infirmier(e) apprend au patient √† devenir autonome et acteur de sa maladie.</p><ul class="list-disc list-inside space-y-2 mt-4 text-slate-700 text-sm"><li><strong>Autosurveillance glyc√©mique :</strong> Apprendre la technique, l'interpr√©tation des r√©sultats et quand la r√©aliser.</li><li><strong>Techniques d'injection de l'insuline :</strong> Choix du mat√©riel, rotation des sites (√©viter les lipodystrophies), conservation.</li><li><strong>Reconnaissance des signes :</strong> Apprendre √† identifier et g√©rer une hypo/hyperglyc√©mie.</li><li><strong>R√®gles hygi√©no-di√©t√©tiques :</strong> Expliquer l'impact de l'alimentation et de l'activit√© physique.</li><li><strong>Soins des pieds :</strong> Inspection quotidienne pour pr√©venir le mal perforant plantaire.</li><li><strong>Gestion des d√©chets :</strong> Utilisation des collecteurs pour objets piquants (DASRI).</li></ul></div>
                        <div class="bg-white/70 backdrop-blur-sm rounded-xl shadow-lg p-6 transition-all duration-300 hover:shadow-2xl hover:-translate-y-1"><div class="flex items-center gap-4 mb-4"><div class="bg-purple-100 w-12 h-12 rounded-full flex items-center justify-center flex-shrink-0"><i data-lucide="eye" class="text-purple-600 w-6 h-6"></i></div><h4 class="text-xl sm:text-2xl font-bold text-slate-800">Surveillance Clinique et Paraclinique</h4></div><p class="text-slate-600">Surveiller l'efficacit√© et la tol√©rance des traitements, et d√©pister les complications.</p><ul class="list-disc list-inside space-y-2 mt-4 text-slate-700 text-sm"><li>Contr√¥le des glyc√©mies capillaires selon la prescription.</li><li>Recherche de c√©tonurie par bandelette urinaire si hyperglyc√©mie > 2,5 g/L.</li><li>Surveillance des param√®tres vitaux (TA, pouls).</li><li>Surveillance de l'√©tat cutan√© (points d'injection, pieds).</li><li>V√©rification de la bonne observance du traitement.</li><li>Suivi du carnet de surveillance du patient.</li></ul></div>
                    </div>
                </section>
            </div>

            <!-- Quiz Page -->
            <div id="quiz" class="page hidden">
                <div class="bg-gradient-to-br from-slate-50 to-gray-100 p-6 sm:p-8 md:p-10 rounded-2xl shadow-inner">
                    <h2 class="text-3xl md:text-4xl font-extrabold text-slate-800 mb-2">Quiz Interactif</h2>
                    <p class="text-slate-600 mb-8">Testez vos connaissances et validez vos acquis sur les antidiab√©tiques.</p>
                    <div id="qcm-container" class="space-y-8"></div>
                    <div id="quiz-footer" class="mt-10 pt-6 border-t-2 border-slate-200 flex justify-between items-center">
                        <p id="quiz-score" class="text-xl md:text-2xl font-bold text-slate-800"></p>
                        <button onclick="resetQuiz()" id="reset-button" class="bg-gradient-to-r from-indigo-500 via-purple-500 to-pink-500 text-white font-semibold py-3 px-6 rounded-xl shadow-lg hover:scale-105 hover:shadow-xl transition-all duration-200 transform opacity-0 pointer-events-none">
                            Recommencer
                        </button>
                    </div>
                </div>
            </div>
        </main>

        <!-- Footer (Replicating Header Style) -->
        <footer id="footer" class="bg-slate-800 text-white p-4 md:p-6 mt-auto">
            <div class="flex items-center justify-center md:justify-end text-center">
                <p class="font-bold text-slate-300 text-xs sm:text-sm">
                    Lucas S√©raudie - <span class="bg-gradient-to-r from-sky-400 via-violet-500 to-pink-500 bg-clip-text text-transparent">IFSI du CHU de Rouen</span> - 2025
                </p>
            </div>
        </footer>

    <script>
        // --- Quiz Data ---
        const quizData = [
            {
                question: "Quelle est la premi√®re mesure th√©rapeutique √† mettre en place pour un diab√®te de type II nouvellement diagnostiqu√© ?",
                options: ["Insulinoth√©rapie", "Metformine", "R√®gles hygi√©no-di√©t√©tiques", "Sulfamides hypoglyc√©miants"],
                correct: 2,
                feedback: "La prise en charge du DT2 d√©bute toujours par des mesures hygi√©no-di√©t√©tiques (alimentation, activit√© physique) pendant 3 √† 6 mois."
            },
            {
                question: "Quel est le principal risque associ√© aux sulfamides hypoglyc√©miants (ex: Diamicron¬Æ) ?",
                options: ["Acidose lactique", "Hypoglyc√©mie", "Infections urinaires", "Troubles digestifs"],
                correct: 1,
                feedback: "Les sulfamides stimulent la s√©cr√©tion d'insuline, ce qui expose √† un risque majeur d'hypoglyc√©mie, surtout chez la personne √¢g√©e ou en cas de je√ªne."
            },
            {
                question: "La metformine (Glucophage¬Æ) est contre-indiqu√©e en cas de :",
                options: ["Hypertension art√©rielle", "Insuffisance r√©nale s√©v√®re", "Hypercholest√©rol√©mie", "Asthme"],
                correct: 1,
                feedback: "L'insuffisance r√©nale s√©v√®re est une contre-indication absolue car elle majore le risque d'acidose lactique, un effet secondaire rare mais tr√®s grave de la metformine."
            },
            {
                question: "Quelle insuline est con√ßue pour mimer la s√©cr√©tion basale du pancr√©as sur 24h, sans pic d'action marqu√© ?",
                options: ["Insuline ultra-rapide (Novorapid¬Æ)", "Insuline interm√©diaire (NPH)", "Analogue lent (Lantus¬Æ)", "M√©lange d'insulines (Novomix¬Æ)"],
                correct: 2,
                feedback: "Les analogues lents comme la glargine (Lantus¬Æ) ou le d√©t√©mir (Levemir¬Æ) ont une dur√©e d'action de 24h et un profil plat pour assurer une couverture basale."
            },
            {
                question: "Un patient diab√©tique de type I, inconscient, est en hypoglyc√©mie s√©v√®re. Quel est le traitement d'urgence ?",
                options: ["Lui donner un jus de fruit", "Injection de Glucagon en IM/SC", "Injection d'insuline rapide", "Attendre qu'il se r√©veille"],
                correct: 1,
                feedback: "Chez un patient inconscient, la voie orale est proscrite. Le glucagon, hormone hyperglyc√©miante, est le traitement de choix en situation extra-hospitali√®re."
            },
            {
                question: "Qu'est-ce que l'h√©moglobine glyqu√©e (HbA1c) mesure ?",
                options: ["La glyc√©mie √† un instant T", "La moyenne des glyc√©mies sur les 3 derniers mois", "Le taux d'insuline dans le sang", "Le nombre de corps c√©toniques"],
                correct: 1,
                feedback: "L'HbA1c est le reflet de l'√©quilibre glyc√©mique sur le long terme (environ 3 mois), c'est l'examen de r√©f√©rence pour le suivi du diab√®te."
            },
            {
                question: "Qu'est-ce qu'une lipodystrophie et comment la pr√©venir ?",
                options: ["Une infection au point d'injection, pr√©venue par l'asepsie", "Une fonte des graisses, pr√©venue par la rotation des sites d'injection", "Une hyperglyc√©mie, pr√©venue par l'insuline", "Une r√©action allergique, pr√©venue par un test cutan√©"],
                correct: 1,
                feedback: "La lipodystrophie est une modification du tissu sous-cutan√© due aux injections r√©p√©t√©es au m√™me endroit. La rotation des sites est essentielle pour la pr√©venir."
            },
            {
                question: "Comment agissent les gliflozines (ex: Invokana¬Æ) ?",
                options: ["Elles stimulent le pancr√©as", "Elles diminuent l'absorption intestinale du sucre", "Elles augmentent l'√©limination du sucre dans les urines", "Elles am√©liorent la sensibilit√© √† l'insuline"],
                correct: 2,
                feedback: "Les gliflozines inhibent le transporteur SGLT2 au niveau du rein, ce qui emp√™che la r√©absorption du glucose et augmente son √©limination urinaire (glycosurie)."
            },
            {
                question: "Quel est le signe clinique caract√©ristique de l'acidoc√©tose diab√©tique ?",
                options: ["La bradycardie", "La dyspn√©e de Kussmaul", "L'hypothermie", "Les sueurs froides"],
                correct: 1,
                feedback: "La dyspn√©e de Kussmaul (respiration ample, rapide et bruyante) est un m√©canisme compensatoire pour √©liminer le CO2 et lutter contre l'acidose m√©tabolique."
            },
            {
                question: "Tous les antidiab√©tiques oraux sont contre-indiqu√©s pendant la grossesse. Quel traitement est utilis√© si les mesures di√©t√©tiques ne suffisent pas ?",
                options: ["La metformine uniquement", "Les sulfamides √† faible dose", "Aucun, on attend l'accouchement", "L'insuline"],
                correct: 3,
                feedback: "L'insuline est le seul traitement antidiab√©tique autoris√© pendant la grossesse car elle ne traverse pas la barri√®re placentaire."
            }
        ];

        // --- Navigation Logic ---
        const pages = ['generalites', 'dt1', 'insulines', 'dt2', 'ado', 'role', 'quiz'];
        const buttonColors = {
            generalites: 'bg-gradient-to-r from-violet-500 to-purple-600 text-white shadow-md',
            dt1: 'bg-gradient-to-r from-teal-500 to-cyan-600 text-white shadow-md',
            insulines: 'bg-gradient-to-r from-sky-500 to-blue-600 text-white shadow-md',
            dt2: 'bg-gradient-to-r from-orange-500 to-red-500 text-white shadow-md',
            ado: 'bg-gradient-to-r from-rose-500 to-pink-500 text-white shadow-md',
            role: 'bg-gradient-to-r from-indigo-500 to-blue-500 text-white shadow-md',
            quiz: 'bg-gradient-to-r from-slate-500 to-gray-700 text-white shadow-md'
        };
        const buttonHoverColors = {
            generalites: 'hover:bg-violet-100 hover:text-violet-800',
            dt1: 'hover:bg-teal-100 hover:text-teal-800',
            insulines: 'hover:bg-sky-100 hover:text-sky-800',
            dt2: 'hover:bg-orange-100 hover:text-orange-800',
            ado: 'hover:bg-rose-100 hover:text-rose-800',
            role: 'hover:bg-indigo-100 hover:text-indigo-800',
            quiz: 'hover:bg-slate-300 hover:text-slate-800'
        };

        function showPage(pageId) {
            pages.forEach(id => {
                document.getElementById(id).classList.add('hidden');
            });
            document.getElementById(pageId).classList.remove('hidden');
            
            const navButtons = document.querySelectorAll('.nav-btn');
            navButtons.forEach(btn => {
                const page = btn.dataset.page;
                btn.className = 'nav-btn w-full py-3 px-2 rounded-lg text-slate-800 font-semibold transition-all duration-300 text-xs sm:text-sm';
                if (page === pageId) {
                    btn.classList.add(...buttonColors[page].split(' '));
                } else {
                    btn.classList.add(...buttonHoverColors[page].split(' '));
                }
            });
        }

        // --- Quiz Logic ---
        function renderQuiz() {
            const container = document.getElementById('qcm-container');
            container.innerHTML = '';
            quizData.forEach((item, index) => {
                const optionsHtml = item.options.map((option, optionIndex) => 
                    `<button class="qcm-option w-full text-left p-4 rounded-xl bg-white border-2 border-slate-200 hover:bg-slate-100 hover:border-slate-300 focus:outline-none focus:ring-2 focus:ring-offset-2 focus:ring-indigo-500 transition-all duration-200" data-index="${optionIndex}">${option}</button>`
                ).join('');

                container.innerHTML += `
                    <div class="qcm-question bg-slate-100/70 border border-slate-200/80 p-6 rounded-2xl shadow-lg" data-question-index="${index}">
                        <p class="font-semibold text-lg text-slate-800 mb-4">${index + 1}. ${item.question}</p>
                        <div class="grid grid-cols-1 sm:grid-cols-2 gap-3">${optionsHtml}</div>
                        <div class="qcm-feedback mt-4 text-sm font-medium"></div>
                    </div>`;
            });
            document.getElementById('quiz-score').textContent = `Pr√™t ? 0 / ${quizData.length}`;
            const resetButton = document.getElementById('reset-button');
            resetButton.classList.add('opacity-0', 'pointer-events-none');
        }

        function setupQuizListeners() {
            const container = document.getElementById('qcm-container');
            container.addEventListener('click', (event) => {
                if (!event.target.classList.contains('qcm-option')) return;
                
                const optionButton = event.target;
                const questionEl = optionButton.closest('.qcm-question');
                if (!questionEl || questionEl.classList.contains('answered')) return;
                
                questionEl.classList.add('answered');
                const questionIndex = parseInt(questionEl.dataset.questionIndex, 10);
                const questionData = quizData[questionIndex];
                const selectedIndex = parseInt(optionButton.dataset.index, 10);
                const isCorrect = selectedIndex === questionData.correct;
                const feedbackEl = questionEl.querySelector('.qcm-feedback');

                if (isCorrect) {
                    optionButton.classList.add('correct');
                    feedbackEl.innerHTML = `<div class="text-emerald-700 p-3 bg-emerald-100 rounded-lg"><b class="font-bold">Bravo !</b> ${questionData.feedback || ''}</div>`;
                } else {
                    optionButton.classList.add('incorrect');
                    questionEl.querySelector(`[data-index="${questionData.correct}"]`).classList.add('correct');
                    feedbackEl.innerHTML = `<div class="text-red-700 p-3 bg-red-100 rounded-lg"><b class="font-bold">Dommage.</b> ${questionData.feedback || ''}</div>`;
                }
                
                questionEl.querySelectorAll('.qcm-option').forEach(btn => btn.disabled = true);
                updateScore();
            });
        }

        function updateScore() {
            const totalQuestions = quizData.length;
            const correctAnswers = document.querySelectorAll('.qcm-option.correct:not(.incorrect):disabled').length;
            const answeredCount = document.querySelectorAll('.qcm-question.answered').length;

            const scoreEl = document.getElementById('quiz-score');
            scoreEl.textContent = `Votre score : ${correctAnswers} / ${answeredCount}`;

            if (answeredCount === totalQuestions) {
                scoreEl.textContent = `Score final : ${correctAnswers} / ${totalQuestions}`;
                const percentage = (correctAnswers / totalQuestions) * 100;
                if (percentage >= 80) {
                    scoreEl.textContent += " - Excellent travail ! üéâ";
                } else if (percentage >= 50) {
                    scoreEl.textContent += " - Pas mal, continuez √† r√©viser ! üí™";
                } else {
                    scoreEl.textContent += " - Encore un effort ! üìö";
                }
                document.getElementById('reset-button').classList.remove('opacity-0', 'pointer-events-none');
            }
        }

        function resetQuiz() {
            renderQuiz();
        }

        // --- Initialisation ---
        document.addEventListener('DOMContentLoaded', () => {
            lucide.createIcons();
            showPage('generalites'); // Show the first page by default
            renderQuiz();
            setupQuizListeners();
        });
    </script>
</body>
</html>

